Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers

US Patent 10064939 · Granted Sep 4, 2018

Assignee

Inventors

View full patent text on Google Patents →